Stuart Barnsher

Stuart Barnsher

Company: Zymeworks

Job title: Senior Scientist


Stuart Barnscher is an Associate Director in the Oncology department at Zymeworks Inc. where he focuses on the discovery and development of antibody-drug conjugate therapeutics. Prior to joining Zymeworks in 2016 via a merger with Kairos Therapeutics, Stuart was instrumental in the development of the ZymeLink antibody-drug conjugate platform technology that occurred at Kairos. Prior to Kairos, Stuart was a synthetic organic chemist at Agensys in the ADC Chemistry group where he designed and synthesized toxins and drug-linkers across multiple payload classes. 

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.